<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Diabetes.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:57 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="1202003">
<meta name="Category" content="Concern">
<meta name="Article" content="Diabetes">
<title>Diabetes-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">Diabetes</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Diabetes.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Hoogeveen EK, Kostense PJ, Jakobs C, et al. Hyperhomocysteinemia increases
risk of death, especially in type 2 diabetes : 5-year follow-up of the Hoorn Study. <em>
Circulation</em> 2000;101:1506&#8211;11.</li>

<li class="Ref">Colditz GA, Manson JE, Stampfer MJ, et al. Diet and risk of clinical diabetes
in women. <em>Am J Clin Nutr</em> 1992;55:1018&#8211;23.</li>

<li class="Ref">Feskens EJ, Bowles CH, Kromhout D. Carbohydrate intake and body mass index in
relation to the risk of glucose intolerance in an elderly population. <em>Am J Clin Nutr</em>
1991;54:136&#8211;40.</li>

<li class="Ref">Wright DW, Hansen RI, Mondon CE, Reaven GM. Sucrose-induced insulin resistance
in the rat: modulation by exercise and diet. <em>Am J Clin Nutr</em>
1983;38:879&#8211;83.</li>

<li class="Ref">Reiser S, Hallfrisch J, Fields M, et al. Effects of sugars on indices of
glucose tolerance in humans. <em>Am J Clin Nutr</em> 1986;43:151&#8211;9.</li>

<li class="Ref">Cohen AM, Bavly S, Poznanski R. Change of diet of Yemenite Jews in relation to
diabetes and ischaemic heart-disease. <em>Lancet</em> 1961;2:1399&#8211;401.</li>

<li class="Ref">Cohen AM, Fidel J, Cohen B, et al. Diabetes, blood lipids, lipoproteins, and
change of environment: restudy of the &#8220;new immigrant Yemenites&#8221; in Israel. <em>
Metabolism</em> 1979;28:716&#8211;28.</li>

<li class="Ref">Feskens EJ, Bowles CH, Kromhout D. Carbohydrate intake and body mass index in
relation to the risk of glucose intolerance in an elderly population. <em>Am J Clin Nutr</em>
1991;54:136&#8211;40.</li>

<li class="Ref">Wolever TMS, Brand Miller J. Sugars and blood glucose control. <em>Am J Clin
Nutr</em> 1995;62:212S&#8211;7S [review].</li>

<li class="Ref">Wolever TMS, Brand Miller J. Sugars and blood glucose control. <em>Am J Clin
Nutr</em> 1995;62:212S&#8211;7S [review].</li>

<li class="Ref">Salmeron J, Manson JE, Stampfer MJ, et al. Dietary fiber, glycemic load, and
risk of non-insulin-dependent diabetes mellitus in women. <em>JAMA</em>
1997;277:472&#8211;7.</li>

<li class="Ref">Salmeron J, Ascherio A, Rimm EB, et al. Dietary fiber, glycemic load, and risk
of NIDDM in men. <em>Diabetes Care</em> 1997;20:545&#8211;50.</li>

<li class="Ref">Feskens EJ, Virtanen SM, Rasanen L, et al. Dietary factors determining
diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts
of the Seven Countries Study. <em>Diabetes Care</em> 1995;18:1104&#8211;12.</li>

<li class="Ref">Salmeron J, Manson JE, Stampfer MJ, et al. Dietary fiber, glycemic load, and
risk of non-insulin-dependent diabetes mellitus in women. <em>JAMA</em>
1997;277:472&#8211;7.</li>

<li class="Ref">Salmeron J, Ascherio A, Rimm EB, et al. Dietary fiber, glycemic load, and risk
of NIDDM in men. <em>Diabetes Care</em> 1997;20:545&#8211;50.</li>

<li class="Ref">Colagiuri S, Miller JJ, Edwards RA. Metabolic effects of adding sucrose and
aspartame to the diet of subjects with noninsulin-dependent diabetes mellitus. <em>Am J Clin
Nutr</em> 1989;50:474&#8211;8.</li>

<li class="Ref">Abraira C, Derler J. Large variations of sucrose in constant carbohydrate
diets in type II diabetes. <em>Am J Med</em> 1988;84:193&#8211;200.</li>

<li class="Ref">Loghmani E, Rickard K, Washburne L, et al. Glycemic response to
sucrose-containing mixed meals in diets of children with insulin-dependent diabetes mellitus.
<em>J Pediatr</em> 1991;119:531&#8211;7.</li>

<li class="Ref">American Diabetes Association. Position Statement: nutrition recommendations
and principles for people with diabetes mellitus. <em>Diabetes Care</em> 1999;22:S42&#8211;5
[review].</li>

<li class="Ref">Brand-Miller J, Foster-Powell K. Diets with a low glycemic index: from theory
to practice. <em>Nutr Today</em> 1999;34:64&#8211;72 [review].</li>

<li class="Ref">Chandalia M, Garg A, Lutjohann D, et al. Beneficial effects of high dietary
fiber intake in patients with type 2 diabetes mellitus. <em>New Engl J Med</em>
2000;342:1392&#8211;8.</li>

<li class="Ref">Florholmen J, Arvidsson-Lenner R, Jorde R, Burhol PG. The effect of Metamucil
on postprandial blood glucose and plasma gastric inhibitory peptide in insulin-dependent
diabetics. <em>Acta Med Scand</em> 1982;212:237&#8211;9.</li>

<li class="Ref">Rodr&#237;guez-Mor&#225;n M, Guerrero-Romero F, Lazcano-Burciaga G. Lipid- and
glucose-lowering efficacy of plantago psyllium in type II diabetes. <em>Diabetes Its
Complications</em> 1998;12:273&#8211;8.</li>

<li class="Ref">Landin K, Holm G, Tengborn L, Smith U. Guar gum improves insulin sensitivity,
blood lipids, blood pressure, and fibrinolysis in healthy men. <em>Am J Clin Nutr</em>
1992;56:1061&#8211;5.</li>

<li class="Ref">Schwartz SE, Levine RA, Weinstock RS, et al. Sustained pectin ingestion:
effect on gastric emptying and glucose tolerance in non-insulin-dependent diabetic patients.
<em>Am J Clin Nutr</em> 1988;48:1413&#8211;7.</li>

<li class="Ref">Hallfrisch J, Scholfield DJ, Behall KM. Diets containing soluble oat extracts
improve glucose and insulin responses of moderately hypercholesterolemic men and women. <em>Am
J Clin Nutr</em> 1995;61:379&#8211;84.</li>

<li class="Ref">Doi K, Matsuura M, Kawara A, Baba S. Treatment of diabetes with glucomannan
(konjac mannan). <em>Lancet</em> 1979;1:987&#8211;8 [letter].</li>

<li class="Ref">Vuksan V, Sievenpiper JL, Owen R, et al. Beneficial effects of viscous dietary
fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a
controlled metabolic trial. <em>Diabetes Care</em> 2000;23:9&#8211;14.</li>

<li class="Ref">Sharma RD, Raghuram TC. Hypoglycaemic effect of fenugreek seeds in non-insulin
dependent diabetic subjects. <em>Nutr Res</em> 1990;10:731&#8211;9.</li>

<li class="Ref">Raghuram TC, Sharma RD, Sivakumar B, Sahay BK. Effect of fenugreek seeds on
intravenous glucose disposition in non-insulin dependent diabetic patients. <em>Phytother
Res</em> 1994;8:83&#8211;6.</li>

<li class="Ref">Nuttall FW. Dietary fiber in the management of diabetes. <em>Diabetes</em>
1993;42:503&#8211;8.</li>

<li class="Ref">Feskens EJM, Bowles CH, Kromhout D. Inverse association between fish intake
and risk of glucose intolerance in normoglycemic elderly men and women. <em>Diabetes Care</em>
1991;14:935&#8211;41.</li>

<li class="Ref">Mori TA, Bao DQ, Burke V, et al. Dietary fish as a major component of a
weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight
hypertensive subjects. <em>Am J Clin Nutr</em> 1999;70:817&#8211;25.</li>

<li class="Ref">Snowdon DA, Phillips RL. Does a vegetarian diet reduce the occurrence of
diabetes? <em>Am J Publ Health</em> 1985;75:507&#8211;12.</li>

<li class="Ref">Crane MG, Sample CJ. Regression of diabetic neuropathy with vegan diet. <em>Am
J Clin Nutr</em> 1988;48:926 [abstract #P28].</li>

<li class="Ref">Crane MG, Sample C. Regression of diabetic neuropathy with total vegetarian
(vegan) diet. <em>J Nutr Med</em> 1994;4:431&#8211;9.</li>

<li class="Ref">Cohen D, Dodds R, Viberti G. Effect of protein restriction in insulin
dependent diabetics at risk of nephropathy. <em>BMJ</em> 1987;294:795&#8211;8.</li>

<li class="Ref">Evanoff G, Thompson C, Bretown J, Weinman E. Prolonged dietary protein
restriction in diabetic nephropathy. <em>Arch Intern Med</em> 1989;149:1129&#8211;33.</li>

<li class="Ref">Gin H, Aparicio M, Potauz L, et al. Low-protein, low-phosphorus diet and
tissue insulin sensitivity in insulin-dependent diabetic patients with chronic renal failure.
<em>Nephron</em> 1991;57:411&#8211;5.</li>

<li class="Ref">Baba NH, Sawaya S, Torbay N, et al. High protein vs high carbohydrate
hypoenergetic diet for the treatment of obese hyperinsulinemic subjects. <em>Int J Obes Relat
Metab Disord</em> 1999;23:1202&#8211;6.</li>

<li class="Ref">Feskens EJ, Virtanen SM, Rasanen L, et al. Dietary factors determining
diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts
of the Seven Countries Study. <em>Diabetes Care</em> 1995;18:1104&#8211;12.</li>

<li class="Ref">Feskens EJ, Kromhout D. Habitual dietary intake and glucose tolerance in
euglycaemic men: the Zutphen Study. <em>Int J Epidemiol</em> 1990;19:953&#8211;9.</li>

<li class="Ref">Marshall JA, Hoag S, Shetterly S, et al. Dietary fat predicts conversion from
impaired glucose tolerance to NIDDM. The San Luis Valley Diabetes Study. <em>Diabetes
Care</em> 1994;17:50&#8211;6.</li>

<li class="Ref">Marshall JA, Hamman RF, Baxter J. High-fat, low-carbohydrate diet and the
etiology of non-insulin-dependent diabetes mellitus: the San Luis Valley Diabetes Study. <em>
Am J Epidemiol</em> 1991;134:590&#8211;603.</li>

<li class="Ref">Uusitupa M, Schwab U, Makimattila S, et al. Effects of two high-fat diets with
different fatty acid compositions on glucose and lipid metabolism in healthy young women. <em>
Am J Clin Nutr</em> 1994;59:1310&#8211;6.</li>

<li class="Ref">Sarkkinen E, Schwab U, Niskanen L, et al. The effects of monounsaturated-fat
enriched diet and polyunsaturated-fat enriched diet on lipid and glucose metabolism in
subjects with impaired glucose tolerance. <em>Eur J Clin Nutr</em> 1996;50:592&#8211;8.</li>

<li class="Ref">Garg A, Bananome A, Grundy SM, et al. Comparison of a high-carbohydrate diet
with a high-monounsaturated-fat diet in patients with non-insulin dependent diabetes mellitus.
<em>N Engl J Med</em> 1988;319:829&#8211;34.</li>

<li class="Ref">Donaghue KC, Pena MM, Chan AK, et al. Beneficial effects of increasing
monounsaturated fat intake in adolescents with type 1 diabetes. <em>Diabetes Res Clin
Pract</em> 2000;48:193&#8211;9.</li>

<li class="Ref">Muntoni S, Cocco P, Aru G, Cucca F. Nutritional factors and worldwide
incidence of childhood type 1 diabetes. <em>Am J Clin Nutr</em> 2000;71:1525&#8211;9.</li>

<li class="Ref">Dahl-Jorgensen K, Joner G, Hanssen KF. Relationship between cows&#8217; milk
consumption and incidence of IDDM in childhood. <em>Diabetes Care</em>
1991;14:1081&#8211;3.</li>

<li class="Ref">Coleman DL, Kuzava JE, Leiter EH. Effect of diet on incidence of diabetes in
nonobese diabetic mice. <em>Diabetes</em> 1990;39:432&#8211;6.</li>

<li class="Ref">Gerstein H. Cow&#8217;s milk exposure and type I diabetes mellitus. <em>
Diabetes Care</em> 1994;17:13&#8211;9.</li>

<li class="Ref">Virtanen SM, Laara E, Hypponen E, et al. Cow&#8217;s milk consumption,
HLA&#8211;DQB1 genotype, and type I diabetes. <em>Diabetes</em> 2000;49:912&#8211;7.</li>

<li class="Ref">Hypponen E, Kenward MG, Virtanen SM, et al. Infant feeding, early weight gain,
and risk of type I diabetes. <em>Diabetes Care</em> 1999;22:1961&#8211;5.</li>

<li class="Ref">Verge CF, Howard NJ, Irwig L, et al. Environmental factors in childhood IDDM.
A population-based, case-control study. <em>Diabetes Care</em> 1994;17:1381&#8211;9.</li>

<li class="Ref">Bodington MJ, McNallyPG, Burden AC. Cow&#8217;s milk and type I childhood
diabetes: no increase in risk. <em>Diabetes Med</em> 1994;11:663&#8211;5.</li>

<li class="Ref">Wadsworth EJ, Shield JP, Hunt LP, Baum JD. A case-control study of
environmental factors associated with diabetes in the under 5&#8217;s. <em>Diabetes Med</em>
1997;14:390&#8211;6.</li>

<li class="Ref">Dahlquist G, Blom L, Lonnberg G. The Swedish Childhood Diabetes Study&#8212;a
multivariate analysis of risk determinants for diabetes in different age groups. <em>
Diabetologia</em> 1991;34:757&#8211;62.</li>

<li class="Ref">Elliott RB, Harris DP, Hill JP, et al. Type I (insulin-dependent) diabetes
mellitus and cow milk: casein variant consumption. <em>Diabetologia</em>
1999;42:292&#8211;6.</li>

<li class="Ref">Karajalainen J, Martin JM, Knip M, et al. A bovine albumin peptide as a
possible trigger of insulin-dependent diabetes mellitus. <em>N Engl J Med</em>
1992;327:302&#8211;7.</li>

<li class="Ref">Scott FWE, Norris JM, Kolb H. Milk and type I diabetes. <em>Diabetes Care</em>
1996;19:379&#8211;83 [review].</li>

<li class="Ref">Atkinson MA, Bowman MA, Kao K-J, et al. Lack of immune responsiveness to
bovine serum albumin in insulin-dependent diabetes. <em>N Engl J Med</em>
1993;329:1853&#8211;8.</li>

<li class="Ref">Gerstein H. Cow&#8217;s milk exposure and type I diabetes mellitus. <em>
Diabetes Care</em> 1994;17:13&#8211;9.</li>

<li class="Ref">Akerblom HK, Knip M. Putative environmental factors in Type 1 diabetes. <em>
Diabetes Metab Rev</em> 1998;14:31&#8211;67 [review].</li>

<li class="Ref">Hypp&#246;nen E, Kenward MG, Virtanen SM, et al. Infant feeding, early weight
gain, and risk of type 1 diabetes. <em>Diabetes Care</em> 1999;22:1961&#8211;5.</li>

<li class="Ref">Pettit DJ, Forman MR, Hanson RL, et al. Breast feeding and incidence of
non-insulin-dependent diabetes mellitus in Pima Indians. <em>Lancet</em>
1997;350:166&#8211;8.</li>

<li class="Ref">Isida K, Mizuno A, Murakami T, Shima K. Obesity is necessary but not
sufficient for the development of diabetes mellitus. <em>Metabolism</em>
1996;45:1288&#8211;95.</li>

<li class="Ref">Casassus P, Fontbonne A, Thibult N, et al. Upper-body fat distribution: a
hyperinsulinemia-independent predictor of coronary heart disease mortality. <em>
Arterioscler</em>&nbsp;<em>Thromb</em> 1992;1387&#8211;92.</li>

<li class="Ref">Karter AJ, Mayer-Davis EJ, Selby JV, et al. Insulin sensitivity and abdominal
obesity in African-American, Hispanic, and non-Hispanic white men and women. <em>Diabetes</em>
1996;45:1547&#8211;55.</li>

<li class="Ref">Park KS, Hree BD, Lee K-U, et al. Intra-abdominal fat is associated with
decreased insulin sensitivity in healthy young men. <em>Metabolism</em>
1991;40:600&#8211;3.</li>

<li class="Ref">Long SD, Swanson MS, O&#8217;Brien K, et al. Weight loss in severely obese
subjects prevents the progression of impaired glucose tolerance to type II diabetes. <em>
Diabetes Care</em> 1994;17:372.</li>

<li class="Ref">Pi-Sunyer FX. Weight and non-insulin-dependent diabetes mellitus. <em>Am J
Clin Nutr</em> 1996;63(suppl):426S&#8211;9S.</li>

<li class="Ref">Wing RR, Marcuse MD, Blair EH, et al. Caloric restriction per se is a
significant factor in improvements in glycemic control and insulin sensitivity during weight
loss in obese NIDDM patients. <em>Diabetes Care</em> 1994;17:30.</li>

<li class="Ref">Henry RR, Gumbiner B. Benefits and limitations of very-low-calorie diet
therapy in obese NIDDM. <em>Diabetes Care</em> 1991;14:802&#8211;23.</li>

<li class="Ref">Hypp&#246;nen E, Kenward MG, Virtanen SM, et al. Infant feeding, early weight
gain, and risk of type 1 diabetes. <em>Diabetes Care</em> 1999;22:1961&#8211;5.</li>

<li class="Ref">Hersey WC, Graves JE, Pollock ML, et al. Endurance exercise training improves
body composition and plasma insulin responses in 70- to 79-year-old men and women. <em>
Metabol</em> 1994;43:847&#8211;54.</li>

<li class="Ref">Rasmussen OW, Lauszus FF, Hermansen K. Effects of postprandial exercise on
glycemic response in IDDM subjects. <em>Diabetes Care</em> 1994;17:1203.</li>

<li class="Ref">Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS. Physical activity and
reduced occurrence of non-insulin-dependent diabetes mellitus. <em>N Engl J Med</em>
1991;325:147&#8211;52.</li>

<li class="Ref">Grimm J-J, Muchnick S. Type I diabetes and marathon running. <em>Diabetes
Care</em> 1993;16:1624 [letter].</li>

<li class="Ref">Bell DSH. Exercise for patients with diabetes&#8212;benefits, risks,
precautions. <em>Postgrad Med</em> 1992;92:183&#8211;96 [review].</li>

<li class="Ref">Ligtenberg PC, Blans M, Hoekstra JB, et al. No effect of long-term physical
activity on the glycemic control in type 1 diabetes patients: a cross-sectional study. <em>
Neth J Med</em> 1999;55:59&#8211;63.</li>

<li class="Ref">Kiechl S, Willeit J, Poewe W, et al. Insulin sensitivity and regular alcohol
consumption: large, prospective, cross sectional population study Bruneck study. <em>BMJ</em>
1996;313:1040&#8211;4.</li>

<li class="Ref">Facchini F, Chen Y-DI, Reaven GM. Light-to-moderate alcohol intake is
associated with enhanced insulin sensitivity. <em>Diabetes Care</em> 1994;17:115.</li>

<li class="Ref">Rimm EB, Chan J, Stampfer MJ, et al. Prospective study of cigarette smoking,
alcohol use, and the risk of diabetes in men. <em>BMJ</em> 1995;310:555&#8211;9.</li>

<li class="Ref">Stampfer MJ, Colditz GA, Willett WC, et al. A prospective study of moderate
alcohol drinking and risk of diabetes in women. <em>Am J Epidemiol</em>
1988;128:549&#8211;58.</li>

<li class="Ref">Goden G, Chen X, Desantis R, et al. Effects of ethanol on carbohydrate
metabolism in the elderly. <em>Diabetes</em> 1993;42:28&#8211;34.</li>

<li class="Ref">Ben G, Gnudi L, Maran A, et al. Effects of chronic alcohol intake on
carbohydrate and lipid metabolism in subjects with type II (non-insulin-dependent) diabetes.
<em>Am J Med</em> 1991;90:70.</li>

<li class="Ref">Young RJ, McCulloch DK, Prescott RJ, Clarke PF. Alcohol: another risk factor
for diabetic retinopathy? <em>BMJ</em> 1984;288:1035.</li>

<li class="Ref">Connor H, Marks V. Alcohol and diabetes. A position paper prepared by the
Nutrition Subcommittee of the British Diabetic Association&#8217;s Medical Advisory Committee
and approved by the Executive Council of the British Diabetic Association. <em>Human Nutr Appl
Nutr</em> 1985;39A:393&#8211;9.</li>

<li class="Ref">Ajani UA, Hennekens CH, Spelsberg A, Manson JE. Alcohol consumption and risk
of type 2 diabetes mellitus among US male physicians. <em>Arch Intern Med</em>
2000;160:1025&#8211;30.</li>

<li class="Ref">Wei M, Gibbons LW, Mitchell TL, et al. Alcohol intake and incidence of type 2
diabetes in men. <em>Diabetes Care</em> 2000;23:18&#8211;22.</li>

<li class="Ref">Valmadrid CT, Klein R, Moss SE, et al. Alcohol intake and the risk of coronary
heart disease mortality in persons with older-onset diabetes mellitus. <em>JAMA</em>
1999;282:239&#8211;46.</li>

<li class="Ref">Wei M, Gibbons LW, Mitchell TL, et al. Alcohol intake and incidence of type 2
diabetes in men. <em>Diabetes Care</em> 2000;23:18&#8211;22.</li>

<li class="Ref">Stegmayr B, Lithner F. Tobacco and end stage diabetic nephropathy. <em>
BMJ</em> 1987;295:581&#8211;2.</li>

<li class="Ref">Scala C, LaPorte RE, Dorman JS, et al. Insulin-dependent diabetes mellitus
mortality&#8212;the risk of cigarette smoking. <em>Circulation</em> 1990;82:37&#8211;43.</li>

<li class="Ref">Rimm EB, Manson JE, Stampfer MJ, et al. Cigarette smoking and the risk of
diabetes in women. <em>Am J Public Health</em> 1993;83:211&#8211;4.</li>

<li class="Ref">Rindone JP, Austin M, Luchesi J. Effect of home blood glucose monitoring on
the management of patients with non-insulin dependent diabetes mellitus in the primary care
setting. <em>Am J Manag Care</em> 1997;3:1335&#8211;8.</li>

<li class="Ref">Faas A, Schellevis FG, Van Eijk JT. The efficacy of self-monitoring of blood
glucose in NIDDM subjects. A criteria-based literature review. <em>Diabetes Care</em>
1997;20:1482&#8211;6.</li>

<li class="Ref">[No authors listed.] Position statement: Tests of glycemia in diabetes.
American Diabetes Association. <em>Diabetes Care</em> 2000;23(Suppl 1):S80&#8211;2.</li>

<li class="Ref">Goldstein DE, Little RR, Lorenz RA, et al. Tests of glycemia in diabetes. <em>
Diabetes Care</em> 1995;18:896&#8211;909 [review].</li>

<li class="Ref">Gallichan M. Self monitoring of glucose by people with diabetes: evidence
based practice. <em>BMJ</em> 1997;314:964&#8211;7 [review].</li>

<li class="Ref">Steel LG. Identifying technique errors. Self-monitoring of blood glucose in
the home setting. <em>J Gerontol Nurs</em> 1994;20:9&#8211;12.</li>

<li class="Ref">Foster SA, Goode JV, Small RE. Home blood glucose monitoring. <em>Ann
Pharmacother</em> 1999;33:355&#8211;63 [review].</li>

<li class="Ref">Herepath WB. <em>Journal Provincial Med Surg Soc</em> 1854:374.</li>

<li class="Ref">Offenbacher EG, Pi-Sunyer FX. Beneficial effect of chromium-rich yeast on
glucose tolerance and blood lipids in elderly subjects. <em>Diabetes</em>
1980;29:919&#8211;25.</li>

<li class="Ref">Anderson RA. Chromium in the prevention and control of diabetes. <em>Diabetes
Metab</em> 2000;26:22&#8211;7 [review].</li>

<li class="Ref">Anderson RA. Chromium, glucose intolerance and diabetes. <em>J Am Coll
Nutr</em> 1998;17:548&#8211;55 [review].</li>

<li class="Ref">Evans GW. The effect of chromium picolinate on insulin controlled parameters
in humans. <em>Int J Biosocial Med Res</em> 1989;11:163&#8211;80.</li>

<li class="Ref">Gaby AR, Wright JV. Diabetes. In <em>Nutritional Therapy in Medical Practice:
Reference Manual and Study Guide</em>. Kent, WA: 1996, 54&#8211;64 [review].</li>

<li class="Ref">Anderson RA, Polansky MM, Bryden NA, Canary JJ. Supplemental-chromium effects
on glucose, insulin, glucagon, and urinary chromium losses in subjects consuming controlled
low-chromium diets. <em>Am J Clin Nutr</em> 1991;54:909&#8211;16.</li>

<li class="Ref">Jovanovic L, Gutierrez M, Peterson CM. Chromium supplementation for women with
gestational diabetes. <em>J Trace Elem Exptl Med</em> 1999;12:91&#8211;8.</li>

<li class="Ref">Anderson RA, Polansky MM, Bryden NA, et al. Chromium supplementation of human
subjects: effects on glucose, insulin, and lipid variables. <em>Metabolism</em>
1983;32:894&#8211;9.</li>

<li class="Ref">Urberg M, Zemel MB. Evidence for synergism between chromium and nicotinic acid
in the control of glucose tolerance in elderly humans. <em>Metabolism</em>
1987;36:896&#8211;9.</li>

<li class="Ref">Lee NA, Reasner CA. Beneficial effect of chromium supplementation on serum
triglyceride levels in NIDDM. <em>Diabetes Care</em> 1994;17:1449&#8211;52.</li>

<li class="Ref">Hermann J, Chung H, Arquitt A, et al. Effects of chromium or copper
supplementation on plasma lipids, plasma glucose and serum insulin in adults over age fifty.
<em>J Nutr Elderly</em> 1998;18:27&#8211;45.</li>

<li class="Ref">Sherman L, Glennon JA, Brech WJ, et al. Failure of trivalent chromium to
improve hyperglycemia in diabetes mellitus. <em>Metabolism</em> 1968;17:439&#8211;42.</li>

<li class="Ref">Rabinowitz MB, Gonick HC, Levin SR, Davidson MB. Effects of chromium and yeast
supplements on carbohydrate and lipid metabolism in diabetic men. <em>Diabetes Care</em>
1983;6:319&#8211;27.</li>

<li class="Ref">Uusitupa MI, Kumpulainen JT, Voutilainen E, et al. Effect of inorganic
chromium supplementation on glucose tolerance, insulin response, and serum lipids in
noninsulin-dependent diabetics. <em>Am J Clin Nutr</em> 1983;38:404&#8211;10.</li>

<li class="Ref">Anderson RA, Cheng N, Bryden NA, et al. Elevated intakes of supplemental
chromium improve glucose and insulin variables in individuals with type 2 diabetes. <em>
Diabetes</em> 1997;46:1786&#8211;91.</li>

<li class="Ref">Gaby AR, Wright JV. Nutritional protocols: diabetes mellitus. In <em>
Nutritional Therapy in Medical Practice: Protocols and Supporting Information.</em> Kent, WA:
1996, 10.</li>

<li class="Ref">Paolisso G, Scheen A, D&#8217;Onofrio FD, Lefebvre P. Magnesium and glucose
homeostasis. <em>Diabetologia</em> 1990;33:511&#8211;4 [review].</li>

<li class="Ref">Eibl NL, Schnack CJ, Kopp H-P, et al. Hypomagnesemia in type II diabetes:
effect of a 3-month replacement therapy. <em>Diabetes Care</em> 1995;18:188.</li>

<li class="Ref">Paolisso G, Sgambato S, Pizza G, et al. Improved insulin response and action
by chronic magnesium administration in aged NIDDM subjects. <em>Diabetes Care</em>
1989;12:265&#8211;9.</li>

<li class="Ref">Lima M, Cruz T, Carreiro Pousada J, et al: The effect of magnesium
supplementation in increasing doses on the control of type 2 diabetes. <em>Diabetes Care</em>
1998;21:682&#8211;6.</li>

<li class="Ref">Paolisso G, Sgambato S, Gambardella A, et al. Daily magnesium supplements
improve glucose handling in elderly subjects. <em>Am J Clin Nutr</em>
1992;55:1161&#8211;7.</li>

<li class="Ref">Smellie WS, O&#8217;Reilly DS, Martin BJ, Santamaria J. Magnesium replacement
and glucose tolerance in elderly subjects. <em>Am J Clin Nutr</em> 1993;57:594&#8211;6
[letter].</li>

<li class="Ref">Sjorgren A, Floren CH, Nilsson A. Oral administration of magnesium hydroxide
to subjects with insulin dependent diabetes mellitus. <em>Magnesium</em>
1988;121:16&#8211;20.</li>

<li class="Ref">de Valk HW, Verkaaik R, van Rijn HJM, et al. Oral magnesium supplementation in
insulin-requiring type 2 diabetic patients. <em>Diabet Med</em> 1998;15:503&#8211;7.</li>

<li class="Ref">McNair P, Christiansen C, Madsbad S, et al. Hypomagnesemia, a risk factor in
diabetic retinopathy. <em>Diabetes</em> 1978;27:1075&#8211;7.</li>

<li class="Ref">Mimouni F, Miodovnik M, Tsang RC, et al. Decreased maternal serum magnesium
concentration and adverse fetal outcome in insulin-dependent diabetic women. <em>Obstet
Gynecol</em> 1987;70:85&#8211;9.</li>

<li class="Ref">American Diabetes Association. Magnesium supplementation in the treatment of
diabetes. <em>Diabetes Care</em> 1992;15:1065&#8211;7.</li>

<li class="Ref">Konrad T, Vicini P, Kusterer K, et al. alpha lipoic acid treatment decreases
serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese
patients with type 2 diabetes. <em>Diabetes Care</em> 1999;22:280&#8211;7.</li>

<li class="Ref">Ruhnau KJ, Meissner HP, Finn JR, et al. Effects of 3-week oral treatment with
the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy. <em>
Diabet Med</em> 1999;16:1040&#8211;3.</li>

<li class="Ref">Ruhnau KJ, Meissner HP, Finn JR, et al. Effects of 3-week oral treatment with
the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy. <em>
Diabet Med</em> 1999;16:1040&#8211;3.</li>

<li class="Ref">Reljanovic M, Reichel G, Rett K, et al. Treatment of diabetic polyneuropathy
with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized
double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy.
<em>Free Radic Res</em> 1999;31:171&#8211;9.</li>

<li class="Ref">Ziegler D, Schatz H, Conrad F, et al. Effects of treatment with the
antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month
randomized controlled multicenter trial (DEKAN Study). <em>Diabetes Care</em>
1997;20:369&#8211;73.</li>

<li class="Ref">Jacob S, Ruus P, Hermann R, et al. Oral administration of RAC-alpha-lipoic
acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a
placebo-controlled pilot trial. <em>Free Radic Biol Med</em> 1999;27:309&#8211;14.</li>

<li class="Ref">Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic
polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized
controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic
Neuropathy. <em>Diabetes Care</em> 1999;22:1296&#8211;301.</li>

<li class="Ref">Morcos M, Borcea V, Isermann B, et al. Effect of alpha-lipoic acid on the
progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an
exploratory study. <em>Diabetes Res Clin Pract</em> 2001;52:175&#8211;83.</li>

<li class="Ref">Jamal GA, Carmichael H. The effect of gamma-linolenic acid on human diabetic
peripheral neuropathy: a double-blind placebo-controlled trial. <em>Diabet Med</em>
1990;7:319&#8211;23.</li>

<li class="Ref">Doi K. Effect of konjac fibre (glucomannan) on glucose and lipids. <em>Eur J
Clin Nutr</em> 1995;49(Suppl. 3):S190&#8211;7 [review].</li>

<li class="Ref">Melga P, Giusto M, Ciuchi E, et al. Dietary fiber in the dietetic therapy of
diabetes mellitus. Experimental data with purified glucomannans. <em>Riv Eur Sci Med
Farmacol</em> 1992;14:367&#8211;73 [in Italian].</li>

<li class="Ref">Huang CY, Zhang MY, Peng SS, et al. Effect of Konjac food on blood glucose
level in patients with diabetes. <em>Biomed Environ Sci</em> 1990;3:123&#8211;31.</li>

<li class="Ref">Vuksan V, Jenkins DJ, Spadafora P, et al. Konjac-mannan (glucomannan) improves
glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A
randomized controlled metabolic trial. <em>Diabetes Care</em> 1999;22:913&#8211;9.</li>

<li class="Ref">Vorster HH, Lotter AP, Odendaal I, et al. Benefits from supplementation of the
current recommended diabetic diet with gel fibre. <em>Int Clin Nutr Rev</em>
1988;8:140&#8211;6.</li>

<li class="Ref">Cesa F, Mariani S, Fava A, et al. The use of vegetable fibers in the treatment
of pregnancy diabetes and/or excessive weight gain during pregnancy. <em>Minerva Ginecol</em>
1990;42:271&#8211;4 [in Italian].</li>

<li class="Ref">Knekt P, Reunanen A, Marniumi J, et al. Low vitamin E status is a potential
risk factor for insulin-dependent diabetes mellitus. <em>J Intern Med</em>
1999;245:99&#8211;102.</li>

<li class="Ref">Salonen JT, Nyssonen K, Tuomainen T-P, et al. Increased risk of non-insulin
dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up
study in men. <em>BMJ</em> 1995;311:1124&#8211;7.</li>

<li class="Ref">Bierenbaum ML, Noonan FJ, Machlin LJ, et al. The effect of supplemental
vitamin E on serum parameters in diabetics, post coronary and normal subjects. <em>Nutr Rep
Int</em> 1985;31:1171&#8211;80.</li>

<li class="Ref">Paolisso G, D&#8217;Amore A, Giugliano D, et al. Pharmacologic doses of
vitamin E improve insulin action in healthy subjects and non-insulin dependent diabetic
patients. <em>Am J Clin Nutr</em> 1993;57:650&#8211;6.</li>

<li class="Ref">Paolisso G, D&#8217;Amore A, Galzerano D, et al. Daily vitamin E supplements
improve metabolic control but not insulin secretion in elderly type II diabetic patients. <em>
Diabetes Care</em> 1993;16:1433&#8211;7.</li>

<li class="Ref">T&#252;t&#252;nc&#252; NB, Bayraktar M, Varli K. Reversal of defective nerve
condition with vitamin E supplementation in type 2 diabetes. <em>Diabetes Care</em>
1998;21:1915&#8211;8.</li>

<li class="Ref">Paolisso G, Di Maro G, Galzerano D, et al. Pharmacological doses of vitamin E
and insulin action in elderly subjects. <em>Am J Clin Nutr</em> 1994;59:1291&#8211;6.</li>

<li class="Ref">Paolisso G, Gambardella A, Galzerano D, et al. Antioxidants in adipose tissue
and risk of myocardial infarction. <em>Lancet</em> 1994;343:596 [letter].</li>

<li class="Ref">T&#252;t&#252;nc&#252; NB, Bayraktar M, Varli K. Reversal of defective nerve
condition with vitamin E supplementation in type 2 diabetes. <em>Diabetes Care</em>
1998;21:1915&#8211;8.</li>

<li class="Ref">Ross WM, Creighton MO, Stewart-DeHaan PJ, et al. Modelling cortical
cataractogenesis: 3. In vivo effects of vitamin E on cataractogenesis in diabetic rats. <em>
Can J Ophthalmol</em> 1982;17:61.</li>

<li class="Ref">Bursell SE, Schlossman DK, Clermont AC, et al. High-dose vitamin E
supplementation normalizes retinal blood flow and creatinine clearance in patients with type I
diabetes. <em>Diabetes Care</em> 1999;22:1245&#8211;51.</li>

<li class="Ref">Ceriello A, Giugliano D, Quatraro A, et al. Vitamin E reduction of protein
glycosylation in diabetes. <em>Diabetes Care</em> 1991;14:68&#8211;72.</li>

<li class="Ref">Duntas L, Kemmer TP, Vorberg B, Scherbaum W. Administration of
d-alpha-tocopherol in patients with insulin-dependent diabetes mellitus. <em>Curr Ther
Res</em> 1996;57:682&#8211;90.</li>

<li class="Ref">Paolisso G, D&#8217;Amore A, Galzerano D, et al. Daily vitamin E supplements
improve metabolic control but not insulin secretion in elderly type II diabetic patients. <em>
Diabetes Care</em> 1993;16:1433&#8211;7.</li>

<li class="Ref">Jain SK, McVie R, Jaramillo JJ, et al. Effect of modest vitamin E
supplementation on blood glycated hemoglobin and triglyceride levels and red cell indices in
type I diabetic patients. <em>J Am Coll Nutr</em> 1996;15:458&#8211;61.</li>

<li class="Ref">Jain SK, McVie R, Smith T. Vitamin E supplementation restores glutathione and
malondialdehyde to normal concentrations in erythrocytes of type 1 diabetic children. <em>
Diabetes Care</em> 2000;23:1389&#8211;94.</li>

<li class="Ref">Reaven PD, Barnett J, Herold DA, Edelman S. Effect of vitamin E on
susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to
oxidation and on protein glycation in NIDDM. <em>Diabetes Care</em> 1995;18:807.</li>

<li class="Ref">Bursell S-E, Schlossman DK, Clermont AC, et al. High-dose vitamin E
supplementation normalizes retinal blood flow and creatineine clearance in patients with type
I diabetes. <em>Diabetes Care</em> 1999;22:1245&#8211;51.</li>

<li class="Ref">Fuller CJ, Chandalia M, Garg A, et al. RRR-alpha-tocopheryl acetate
supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative
susceptibility but not protein glycation in patients with diabetes mellitus. <em>Am J Clin
Nutr</em> 1996;63:753&#8211;9.</li>

<li class="Ref">Skrha J, Sindelka G, Kvasnicka J, Hilgertova J. Insulin action and
fibrinolysis influenced by vitamin E in obese type 2 diabetes mellitus. <em>Diabetes Res Clin
Pract</em> 1999;44:27&#8211;33.</li>

<li class="Ref">Lepp&#228;l&#228; JM, Virtamo J, Fogelholm R, et al. Vitamin E and beta
carotene supplementation in high risk for stroke: A subgroup analysis of the alpha-tocopherol,
beta-carotene cancer prevention study. <em>Arch Neurol</em> 2000;57:1503&#8211;9.</li>

<li class="Ref">Cunningham JJ, Ellis SL, McVeigh KL, et al. Reduced mononuclear leukocyte
ascorbic acid content in adults with insulin-dependent diabetes mellitus consuming adequate
dietary vitamin C. <em>Metabolism</em> 1991;40:146&#8211;9.</li>

<li class="Ref">Davie SJ, Gould BJ, Yudkin JS. Effect of vitamin C on glycosylation of
proteins. <em>Diabetes</em> 1992;41:167&#8211;73.</li>

<li class="Ref">Will JC, Tyers T. Does diabetes mellitus increase the requirement for vitamin
C? <em>Nutr Rev</em> 1996;54:193&#8211;202 [review].</li>

<li class="Ref">Eriksson J, Kohvakka A. Magnesium and ascorbic acid supplementation in
diabetes mellitus. <em>Ann Nutr Metab</em> 1995;39:217&#8211;23.</li>

<li class="Ref">Paolisso G, Balbi V, Volpe C, et al. Metabolic benefits deriving from chronic
vitamin C supplementation in aged non-insulin dependent diabetics. <em>J Am Coll Nutr</em>
1995;14:387&#8211;92.</li>

<li class="Ref">Will JC, Tyers T. Does diabetes mellitus increase the requirement for vitamin
C? <em>Nutr Rev</em> 1996;54:193&#8211;202 [review].</li>

<li class="Ref">McAuliffe AV, Brooks BA, Fisher EJ, et al. Administration of ascorbic acid and
an aldose reductase inhibitor (tolrestat) in diabetes: effect on urinary albumin excretion.
<em>Nephron</em> 1998;80:277&#8211;84.</li>

<li class="Ref">Branch DR. High-dose vitamin C supplementation increases plasma glucose. <em>
Diabetes Care</em> 1999;22:1218 [letter].</li>

<li class="Ref">Mayer-Davis E, Bell RA, Reboussin BA, et al. Antioxidant nutrient intake and
diabetic retinopathy. The San Luis Valley Diabetes Study. <em>Ophthalmology</em>
1998;105:2264&#8211;70.</li>

<li class="Ref">Wilson RG, Davis RE. Serum pyridoxal concentrations in children with diabetes
mellitus. <em>Pathology</em> 1977;9:95&#8211;9.</li>

<li class="Ref">Davis RE, Calder JS, Curnow DH. Serum pyridoxal and folate concentrations in
diabetics. <em>Pathology</em> 1976;8:151&#8211;6.</li>

<li class="Ref">McCann VJ, Davis RE. Serum pyridoxal concentrations in patients with diabetic
neuropathy. <em>Aust N Z J Med</em> 1978;8:259&#8211;61.</li>

<li class="Ref">Spellacy WN, Buhi WC, Birk SA. Vitamin B6 treatment of gestational diabetes
mellitus. <em>Am J Obstet Gynecol</em> 1977;127:599&#8211;602.</li>

<li class="Ref">Coelingh HJT, Schreurs WHP. Improvement of oral glucose tolerance in
gestational diabetes by pyridoxine. <em>BMJ</em> 1975;3:13&#8211;5.</li>

<li class="Ref">Spellacy WN, Buhi WC, Birk SA. The effects of vitamin B6 on carbohydrate
metabolism in women taking steroid contraceptives: preliminary report. <em>Contraception</em>
1972;6:265&#8211;73.</li>

<li class="Ref">Passariello N, Fici F, Giugliano D, et al. Effects of pyridoxine
alpha-ketoglutarate on blood glucose and lactate in type I and II diabetics. <em>Int J Clin
Pharmacol Ther Toxicol</em> 1983;21:252&#8211;6.</li>

<li class="Ref">Solomon LR, Cohen K. Erythrocyte O2 transport and metabolism and effects of
vitamin B6 therapy in type II diabetes mellitus. <em>Diabetes</em> 1989;38:881&#8211;6.</li>

<li class="Ref">Rao RH, Vigg BL, Rao KSJ. Failure of pyridoxine to improve glucose tolerance
in diabetics. <em>J Clin Endocrinol Metab</em> 1980;50:198&#8211;200.</li>

<li class="Ref">Coggeshall JC, Heggers JP, Robson MC, Baker H. Biotin status and plasma
glucose in diabetics. <em>Ann NY Acad Sci</em> 1985;447:389&#8211;92.</li>

<li class="Ref">Maebashi M, Makino Y, Furukawa Y, et al. Therapeutic evaluation of the effect
of biotin on hyperglycemia in patients with non-insulin dependent diabetes mellitus. <em>J
Clin Biochem Nutr</em> 1993;14:211&#8211;8.</li>

<li class="Ref">Koutsikos D, Agroyannis B, Tzanatos-Exarchou H. Biotin for diabetic peripheral
neuropathy. <em>Biomed Pharmacother</em> 1990;44:511&#8211;4.</li>

<li class="Ref">Haugen HN. The blood concentration of thiamine in diabetes. <em>Scand J Clin
Lab Invest</em> 1964;16:260&#8211;6.</li>

<li class="Ref">Vorhaus MG, Williams RR, Waterman RE. Studies on crystalline vitamin B1:
observations in diabetes. <em>Am J Dig Dis</em> 1935;2:541&#8211;57.</li>

<li class="Ref">Abbas ZG, Swai ABM. Evaluation of the efficacy of thiamine and pyridoxine in
the treatment of symptomatic diabetic peripheral neuropathy. <em>East African Med J</em>
1997;74:804&#8211;8.</li>

<li class="Ref">Stracke H, Lindemann A, Federlin K. A benfotiamine-vitamin B combination in
treatment of diabetic polyneuropathy. <em>Exp Clin Endocrinol Diabetes</em>
1996;104:311&#8211;6.</li>

<li class="Ref">Miyake Y, Shouzu A, Nishikawa M, et al. Effect of treatment of
3-hydroxy-3-methylglutaryl coenzyme I reductase inhibitors on serum coenzyme Q10 in diabetic
patients. <em>Arzneimittelforschung</em> 1999;49:324&#8211;9.</li>

<li class="Ref">Shigeta Y, Izumi K, Abe H. Effect of coenzyme Q7 treatment on blood sugar and
ketone bodies of diabetics. <em>J Vitaminol (Kyoto)</em> 1966;12:293&#8211;8.</li>

<li class="Ref">Henriksen JE, Bruun Andersen C, Hother-Nielsen O, et al. Impact of ubiquinone
(coenzyme Q10) treatment on glycaemic control, insulin requirement and well-being in patients
with Type 1 diabetes mellitus. <em>Diabet Med</em> 1999;16:312&#8211;8.</li>

<li class="Ref">Abdel-Aziz MT, Abdou MS, Soliman K, et al. Effect of carnitine on blood lipid
pattern in diabetic patients. <em>Nutr Rep Int</em> 1984;29:1071&#8211;9.</li>

<li class="Ref">Onofrj M, Fulgente T, Mechionda D, et al. L-acetylcarnitine as a new
therapeutic approach for peripheral neuropathies with pain. <em>Int J Clin Pharmacol Res</em>
1995;15:9&#8211;15.</li>

<li class="Ref">Yamane K, Usui T, Yamamoto T, et al. Clinical efficacy of intravenous plus
oral mecobalamin in patients with peripheral neuropathy using vibration perception thresholds
as an indicator of improvement. <em>Curr Ther Res</em> 1995;56:656&#8211;70 [review].</li>

<li class="Ref">Kuwabara S, Nakazawa R, Azuma N, et al. Intravenous methylcobalamin treatment
for uremic and diabetic neuropathy in chronic hemodialysis patients. <em>Intern Med</em>
1999;38:472&#8211;5.</li>

<li class="Ref">Molnar GD, Berge KG, Rosevear JW, et al. The effect of nicotinic acid in
diabetes mellitus. <em>Metabolism</em> 1964;13:181&#8211;9.</li>

<li class="Ref">Gaut ZN, Pocelinko R, Solomon HM, Thomas GB. Oral glucose tolerance, plasma
insulin, and uric acid excretion in man during chronic administration in nicotinic acid. <em>
Metabolism</em> 1971;20:1031&#8211;5.</li>

<li class="Ref">Clearly JP. The importance of oxidant injury as a cause of impaired
mitochondrial oxidation in diabetes. <em>J Orthomolec Med</em> 1988;3:164&#8211;74.</li>

<li class="Ref">Clearly JP. Vitamin B3 in the treatment of diabetes mellitus: case reports and
review of the literature. <em>J Nutr Med</em> 1990;1:217&#8211;25.</li>

<li class="Ref">Lewis CM, Canafax DM, Sprafka JM, Bazrbosa JJ. Double-blind randomized trail
of nicotinamide on early-onset diabetes. <em>Diabetes Care</em> 1992;15:121&#8211;3.</li>

<li class="Ref">Chase HP, Butler-Simon N, Garg S, et al. A trial of nicotinamide in newly
diagnosed patients with type 1 (insulin-dependent) diabetes mellitus. <em>Diabetologia</em>
1990;33:444&#8211;6.</li>

<li class="Ref">Mendola G, Casamitjana R, Gomis R. Effect of nicotinamide therapy upon B-cell
function in newly diagnosed type 1 (insulin-dependent) diabetic patients. <em>
Diabetologia</em> 1989;32:160&#8211;2.</li>

<li class="Ref">Pozzilli P, Browne PD, Kolb H. Meta-analysis of nicotinamide treatment in
patients with recent-onset type 1. The nicotinamide trialists. <em>Diabetes Care</em>
1996;19:1357&#8211;63.</li>

<li class="Ref">Vidal J, Fernandez-Balsells M, Sesmilo G, Aguilera E. Effects of nicotinamide
and intravenous insulin therapy in newly diagnosed type 1 diabetes. <em>Diabetes Care</em>
2000;23:360&#8211;4.</li>

<li class="Ref">Elliott RB, Picher CC, Fergusson DM, Stewart AW. A population based strategy
to prevent insulin-dependent diabetes using nicotinamide. <em>J Pediatr Endocrinol Metab</em>
1996;9:501&#8211;9.</li>

<li class="Ref">Lampeter EF, Klinghammer A, Scherbaum WA, et al. The Deutsche Nicotinamide
Intervention Study. An attempt to prevent type 1 diabetes. <em>Diabetes</em>
1998;47:980&#8211;4.</li>

<li class="Ref">Visalli N, Cavallo MG, Signore A, et al. A multi-centre randomized trial of
two different doses of nicotinamide in patients with recent-onset type 1 diabetes (The IMDIAB
VI). <em>Diabetes Metab Res Rev</em> 1999;15:181&#8211;5.</li>

<li class="Ref">Nakamura T, Higashi A, Nishiyama S, et al. Kinetics of zinc status in children
with IDDM. <em>Diabetes Care</em> 1991;14:553&#8211;7.</li>

<li class="Ref">Mocchegiani E, Boemi M, Fumelli P, Fabris N. Zinc-dependent low thymic hormone
level in type I diabetes. <em>Diabetes</em> 1989;12:932&#8211;7.</li>

<li class="Ref">Rao KVR, Seshiah V, Kumar TV. Effect of zinc sulfate therapy on control and
lipids in type I diabetes. <em>J Assoc Physicians India</em> 1987;35:52 [abstract].</li>

<li class="Ref">Niewoehner CB, Allen JI, Boosalis M, et al. Role of zinc supplementation in
type II diabetes mellitus. <em>Am J Med</em> 1986;81:63&#8211;8.</li>

<li class="Ref">Pidduck HG, Wren PJ, Evans DA. Hyperzincuria of diabetes mellitus and possible
genetic implications of this observation. <em>Diabetes</em> 1970;19:240&#8211;7.</li>

<li class="Ref">Cunningham JJ, Fu A, Mearkle PL, Brown RG. Hyperzincuria in individuals with
insulin-dependent diabetes mellitus: concurrent zinc status and the effect of high-dose zinc
supplementation. <em>Metabolism</em> 1994;43:1558&#8211;62.</li>

<li class="Ref">Labriji-Mestaghanmi H, Billaudel B, Garnier PE, Sutter BCJ. Vitamin D and
pancreatic islet function. I. Time course for changes in insulin secretion and content during
vitamin deprivation and repletion. <em>J Endocrine Invest</em> 1988;11:577&#8211;84.</li>

<li class="Ref">Boucher BJ. Inadequate vitamin D status: does it contribute to the disorders
comprising syndrome &#8216;X&#8217;? <em>Br J Nutr</em> 1998;79:315&#8211;27 [review].</li>

<li class="Ref">Salway JG, Whitehead L, Finnegan JA, et al. Effect of <em>myo</em>-inositol on
peripheral-nerve function in diabetes. <em>Lancet</em> 1978;2:1282&#8211;4.</li>

<li class="Ref">Franconi F, Bennardini F, Mattana A, et al. Plasma and platelet taurine are
reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine
supplementation. <em>Am J Clin Nutr</em> 1995;61:1115&#8211;9.</li>

<li class="Ref">Nakamura T, Ushiyama C, Suzuki S, et al. Effects of taurine and vitamin E on
microalbuminuria, plasma metalloproteinase-9, and serum type IV collagen concentrations in
patients with diabetic nephropathy. <em>Nephron</em> 1999;83:361&#8211;2.</li>

<li class="Ref">Zak A, Zeman M, Hrabak P, et al. Changes in the glucose tolerance and insulin
secretion in hypertriglyceridemia: effects of dietary n-3 fatty acids. <em>Nutr Rep Int</em>
1989;39:235&#8211;42.</li>

<li class="Ref">Popp-Snijders C, Schouten JA, Heine RJ, et al. Dietary supplementation of
omega-3 polyunsaturated fatty acids improves insulin sensitivity in non-insulin-dependent
diabetes. <em>Diabetes Res</em> 1987;4:141&#8211;7.</li>

<li class="Ref">Albrink MJ, Ullrich IH, Blehschmidt NG, et al. The beneficial effect of fish
oil supplements on serum lipids and clotting function of patients with type II diabetes
mellitus. <em>Diabetes</em> 1986;35 (suppl 1):43A [abstract #172].</li>

<li class="Ref">Wei I, Ulchaker M, Sheehan J. Effect of omega-3 fatty acids (FA) in non-obese
non-insulin dependent diabetes (NIDDM). <em>Am Clin Nutr</em> 1988;47:775 [abstract #70].</li>

<li class="Ref">Vandongen R, Mori TA, Codde JP, et al. Hypercholesterolaemic effect of fish
oil in insulin-dependent diabetic patients. <em>Med J Aust</em> 1988;148:141&#8211;3.</li>

<li class="Ref">Schectman G, Kaul S, Kissebah AH. Effect of fish oil concentrate on
lipoprotein composition in NIDDM. <em>Diabetes</em> 1988;37:1567&#8211;73.</li>

<li class="Ref">Stackpoole PW, Alig J, Kilgore LL, et al. Lipodystrophic diabetes mellitus.
Investigations of lipoprotein metabolism and the effects of omega-3 fatty acid administration
in two patients. <em>Metabolism</em> 1988;37:944&#8211;51.</li>

<li class="Ref">Glauber H, Wallace P, Griver K, Brechtel G. Adverse metabolic effect of
omega-3 fatty acids in non-insulin-dependent diabetes mellitus. <em>Ann Intern Med</em>
1988;108:663&#8211;8.</li>

<li class="Ref">Okuda Y, Mizutani M, Ogawa M, et al. Long-term effects of eicosapentaenoic
acid on diabetic peripheral neuropathy and serum lipids in patients with type II diabetes
mellitus. <em>J Diabetes Complications</em> 1996;10:280&#8211;7.</li>

<li class="Ref">Gaby A. Preventing complications of diabetes <em>Townsend Letter</em>
1985;32:307 [editorial].</li>

<li class="Ref">Halberstam M, Cohen N, Schlimovich P, et al. Oral vanadyl sulfate improves
insulin sensitivity in NIDDM but not in obese nondiabetic subjects. <em>Diabetes</em>
1996;45:659&#8211;66.</li>

<li class="Ref">Boden G, Chen X, Ruiz J, et al. Effects of vanadyl sulfate on carbohydrate and
lipid metabolism in patients with non-insulin dependent diabetes mellitus. <em>Metabolism</em>
1996;45:1130&#8211;5.</li>

<li class="Ref">Goldfine AB, Patti ME, Zuberi L, et al. Metabolic effects of vanadyl sulfate
in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies. <em>
Metabolism</em> 2000;49:400&#8211;10.</li>

<li class="Ref">Aharon Y, Mevorach M, Shamoon H. Vanadyl sulfate does not enhance insulin
action in patients with type 1 diabetes. <em>Diabetes Care</em> 1998;21:2194 [letter].</li>

<li class="Ref">Goldfine AB, Patti ME, Zuberi L, et al. Metabolic effects of vanadyl sulfate
in humans with non-insulin-dependent diabetes mellitus: In vivo and in vitro studies. <em>
Metabolism</em> 2000;49:400&#8211;10.</li>

<li class="Ref">Yamashita K, Kawai K, Itakura M. Effect of fructo-oligosaccharides on blood
glucose and serum lipids in diabetic subjects. <em>Nutr Res</em> 1984;4:961&#8211;6.</li>

<li class="Ref">Roberfroid M. Dietary fibre, inulin and oligofructose. A review comparing
their physiological effects. <em>Crit Rev Food Sci Nutr</em> 1993;33:103&#8211;48
[review].</li>

<li class="Ref">van Dokkum W, Wezendonk B, Srikumar TS, van den Heuvel. Effect of
nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and
glucose absorption in young healthy male subjects. <em>Eur J Clin Nutr</em>
1999;53:1&#8211;7.</li>

<li class="Ref">Luo J, Rizkalla SW, Alamowitch C, et al. Chronic consumption of short-chain
fructooligosaccharides by health subjects decreased basal hepatic glucose production but had
no effect on insulin-stimulated glucose metabolism. <em>Am J Clin Nutr</em>
1996;63:939&#8211;45.</li>

<li class="Ref">Kosenko LG. Concentration of trace elements in the blood of patients with
diabetes mellitus. <em>Fed Proc Transl (Suppl)</em> 1965;24:237&#8211;8.</li>

<li class="Ref">Baly DL, Schneiderman JS, Garcia-Welsh AL. Effect of manganese deficiency on
insulin binding, glucose transport and metabolism in rat adipocytes. <em>J Nutr</em>
1990;120:1075&#8211;9.</li>

<li class="Ref">Rubenstein AH, Levin NW, Elliott GA. Hypoglycaemia induced by manganese. <em>
Nature (London)</em> 1962;194:188&#8211;9.</li>

<li class="Ref">Eckel RH, Hanson AS, Chen AY, et al. Dietary substitution of medium-chain
triglycerides improves insulin-mediated glucose metabolism in non-insulin dependent diabetics.
<em>Diabetes</em> 1992;41:641&#8211;7.</li>

<li class="Ref">Trudy J, Yost RN, Erskine JM, et al. Dietary substitution of medium-chain
triglycerides in subjects with non-insulin dependent diabetes mellitus in an ambulatory
setting: impact on glycemic control and insulin-mediated glucose metabolism. <em>J Am Coll
Nutr</em> 1994;13:615&#8211;22.</li>

<li class="Ref">[No authors listed.] Treatment of painful diabetic neuropathy with topical
capsaicin. A multicenter, double-blind, vehicle-controlled study. The Capsaicin Study Group.
<em>Arch Intern Med</em> 1991;151:2225&#8211;9.</li>

<li class="Ref">[No authors listed.] Effect of treatment with capsaicin on daily activities of
patients with painful diabetic neuropathy. Capsaicin Study Group. <em>Diabetes Care</em>
1992;15:159&#8211;65.</li>

<li class="Ref">Anderson JW, Allgood LD, Turner J, et al. Effects of psyllium on glucose and
serum lipid responses in men with type 2 diabetes and hypercholesterolemia. <em>Am J Clin
Nutr</em> 1999;70:466&#8211;73.</li>

<li class="Ref">Zhang T, Hoshino M, Iguchi K, et al. Ginseng root: Evidence for numerous
regulatory peptides and insulinotropic activity. <em>Biomed Res</em> 1990;11:49&#8211;54.</li>

<li class="Ref">Suzuki Y, Hikino H. Mechanisms of hypoglycemic activity of panaxans A and B,
glycans of <em>Panax ginseng</em> roots: Effects on plasma levels, secretion, sensitivity and
binding of insulin in mice. <em>Phytother Res</em> 1989;3:20&#8211;4.</li>

<li class="Ref">Waki I, Kyo H, Yasuda M, Kimura M. Effects of a hypoglycemic component of
ginseng radix on insulin biosynthesis in normal and diabetic animals. <em>J Pharm Dyn</em>
1982;5:547&#8211;54.125.</li>

<li class="Ref">Sotaniemi EA, Haapakoski E, Rautio A. Ginseng therapy in non-insulin-dependent
diabetic patients. <em>Diabetes Care</em> 1995;18:1373&#8211;5.</li>

<li class="Ref">Vuksan V, Sivenpiper JL, Koo VY, et al. American ginseng (<em>Panax
quinquefolius</em> L.) reduces postprandial glycemia in nondiabetic subjects and subjects with
type 2 diabetes mellitus. <em>Arch Intern Med</em> 2000;160:1009&#8211;13.</li>

<li class="Ref">Vuksan V, Sivenpiper JL, Koo VYY, et al. American ginseng (<em>Panax
quinquefolius</em> L.) reduces postprandial glycemia in nondiabetic subjects and subjects with
type 2 diabetes mellitus. <em>Arch Intern Med</em> 2000;160:1009&#8211;13.</li>

<li class="Ref">Viseshakul D, Premvatana P, Chularojmontri V, et al. Improved glucose
tolerance induced by long term dietary supplementation with hairy basal seeds (<em>Ocimum
canum</em> Sim) in diabetics. <em>J Med Assoc Thailand</em> 1985;68:408&#8211;11.</li>

<li class="Ref">Agrawal P, Rai V, Singh RB. Randomized placebo-controlled, single blind trial
of holy basil leaves in patients with noninsulin-dependent diabetes mellitus. <em>Int J Clin
Pharmacol Ther</em> 1996;34:406&#8211;9.</li>

<li class="Ref">Rai V, Mani UV, Iyer UM. Effect of <em>Ocimum sanctum</em> leaf powder on
blood lipoproteins, glycated protein and total amino acids in patients with
non-insulin-dependent diabetes mellitus. <em>J Nutr Environ Med</em> 1997;7:113&#8211;8.</li>

<li class="Ref">Baskaran K, Ahmath BK, Shanmugasundaram KR, Shanmugasundaram ERB. Antidiabetic
effect of a leaf extract from <em>Gymnema sylvestre</em> in non-insulin-dependent diabetes
mellitus patients. <em>J Ethnopharmacol</em> 1990;30:295&#8211;305.</li>

<li class="Ref">Shanmugasundaram ERB, Rajeswari G, Baskaran K, et al. Use of<em>Gymnema
sylvestre</em> leaf extract in the control of blood glucose insulin-dependent diabetes
mellitus. <em>J Ethnopharmacol</em> 1990;30:281&#8211;94.</li>

<li class="Ref">Bunyapraphatsara N, Yongchaiyudha S, Rungpitarangsi V, Chokechaijaroenporn O.
Antidiabetic activity of <em>Aloe vera</em> L juice II. Clinical trial in diabetes mellitus
patients in combination with glibenclamide. <em>Phytomedicine</em> 1996;3:245&#8211;8.</li>

<li class="Ref">Yongchaiyudha S, Rungpitarangsi V, Bunyapraphatsara N, Chokeshaijaroenporn O.
Antidiabetic activity of <em>Aloe vera</em> L juice I. Clinical trial in new cases of diabetes
mellitus. <em>Phytomedicine</em> 1996;3:241&#8211;3.</li>

<li class="Ref">Leatherdale BA, Panesar RK, Singh G, et al. Improvement of glucose tolerance
due to <em>Momordica charantia</em> (karela). <em>BMJ</em> 1981;282:1823&#8211;4.</li>

<li class="Ref">Srivastava Y, Venkatakrishna-bhatt H, Verma Y, et al. Antidiabetic and
adaptogenic properties of <em>Momordica charantia</em> extract: An experimental and clinical
evaluation. <em>Phytother Res</em> 1993;7:285&#8211;9.</li>

<li class="Ref">Welihinda J, Karunanaya E, Sheriff MHB, Jayasinghe K. Effect of Momordica
charantia on the glucose tolerance in maturity onset diabetes. <em>J Ethnopharmacol</em>
1986;17:277&#8211;82.</li>

<li class="Ref">Jain RC, Sachdev KN. A note on hypoglycemic action of onion in diabetes. <em>
Curr Med Pract</em> 1971;15:901&#8211;2.</li>

<li class="Ref">Mathew PT, Augusti KT. Hypoglycaemic effect of onion, <em>Allium cepa</em>
Linn, on diabetes mellitus, a preliminary report. <em>Ind J Physiol Pharmacol</em>
1975;19:231&#8211;7.</li>

<li class="Ref">Tjokroprawiro A, Pikir BS, Budhiarta AA, et al. Metabolic effects of onion and
green beans on diabetic patients. <em>Tohoku J Exp Med</em> 1983;141(suppl):671&#8211;6.</li>

<li class="Ref">Sharma KK, Gupta RK, Gupta S, Samuel KC. Antihyperglycemic effect of onion:
Effect on fasting blood sugar and induced hyperglycemia in man. <em>Ind J Med Res</em>
1977;65:422&#8211;9.</li>

<li class="Ref">Scharrer A, Ober M. Anthocyanoside in der Behandlung von Retinopathien. <em>
Klin Monatsblatt Augenheilk</em> 1981;178:386&#8211;9.</li>

<li class="Ref">Koltringer P, Langsteger W, Lind P, et al. [Ginkgo biloba extract and folic
acid in the therapy of changes caused by autonomic neuropathy]. <em>Acta Med Austriaca</em>
1989;16:35&#8211;7 [in German].</li>

<li class="Ref">Gray AM, Flatt PR. Insulin-secreting activity of the traditional antidiabetic
plant <em>Viscum album</em> (mistletoe). <em>J Endocrinol</em> 1999;160:409&#8211;14.</li>

<li class="Ref">Swanson-Flatt SK, Day C, Bailey CJ, Flatt PR. Evaluation of traditional plant
treatments for diabetes: Studies in streptozotocin-diabetic mice. <em>Acta Diabetologica
Latina</em> 1989;26:51&#8211;5.</li>

<li class="Ref">Peirce A. <em>Practical Guide to Natural Medicines</em>. New York: William
Morrow and Co., 1999, 469&#8211;71.</li>

<li class="Ref">Van der Hem LG, van der Vliet JA, Bocken CF, et al. Ling Zhi-8: studies of a
new immunomodulating agent. <em>Transplantation</em> 1995;60:438&#8211;43.</li>

<li class="Ref">Jones K. Reishi mushroom: Ancient medicine in modern times. <em>Alt Compl
Ther</em> 1998;4:256&#8211;66 [review].</li>

<li class="Ref">Feng M, Li Y, Pang B, et al. Acupuncture combined with application of xiaoke
plaster for treatment of 309 cases of diabetes mellitus. <em>J Tradit Chin Med</em>
1997;17:247&#8211;9.</li>

<li class="Ref">Chen JF. A hemorrheological study on the effect of acupuncture in treating
diabetes mellitus. <em>J Tradit Chin Med</em> 1987;7:95&#8211;100.</li>

<li class="Ref">Chen D, Gong D, Zhai Y. Clinical and experimental studies in treating diabetes
mellitus by acupuncture. <em>J Tradit Chin Med</em> 1994;14:163&#8211;6.</li>

<li class="Ref">Chen JF, Wei J. Changes of plasma insulin level in diabetics treated with
acupuncture. <em>J Tradit Chin Med</em> 1985;5:79&#8211;84.</li>

<li class="Ref">Abuaisha BB, Costanzi JB, Boulton AJ. Acupuncture for the treatment of chronic
painful peripheral diabetic neuropathy: a long-term study. <em>Diabetes Res Clin Pract</em>
1998;39:115&#8211;21.</li>

<li class="Ref">Zheg HT, Huang XM, Sun JH. Treatment of diabetic cystopathy by acupuncture and
moxibustion. <em>J Tradit Chin Med</em> 1986;6:243&#8211;8.</li>

<li class="Ref">Zhang W. Acupuncture for treatment of diabetic urinary bladder neural
dysfunction&#8212;a report of 36 cases. <em>J Tradit Chin Med</em> 1997;17:211&#8211;3.</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Diabetes.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:57 GMT -->
</html>

